Clinical trial
Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.
NCT00888797 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2010
- Completion date
- January 31, 2017
- Enrollment
- 400 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.